GAS1’s discovery represents a beacon of hope in the fight against metastatic disease.
Metabolomic profiling uncovers disrupted biochemical pathways in diseases like COPD and aging, highlighting shared and unique mechanisms.
Despite advances, key gaps in understanding insulin resistance persist, including CNS diagnostics, brain-periphery interactions, and apoE isoform roles, highlighting critical research priorities for new treatments.
Genetic and environmental factors affecting NSCLC progression and treatment response necessitate global validation of these envonalkib trial findings.
The molecular events of Stage 2 CKD, from inflammation to lipid metabolism, offer insights for diagnosis and treatment.
As detection methods improve, researchers are poised to uncover the full scope of RNA modifications and their roles in cellular physiology.
The computational modeling of breast cancer invasion provides a transformative lens through which to understand tumor progression.
Originally linked to neural responses and embryonic stem cell maintenance, NAC1 now occupies the spotlight for its multifaceted roles in oncogenesis.
In the quest to improve the lives of individuals with autism spectrum disorder, rigorous science remains our most vital tool—revealing not just what works, but what does not.
Despite advances, key gaps in understanding insulin resistance persist, including CNS diagnostics, brain-periphery interactions, and apoE isoform roles, highlighting critical research priorities for new treatments.
GAS1’s discovery represents a beacon of hope in the fight against metastatic disease.
Working memory, a cornerstone of human cognition, has long been mischaracterized as a passive storage system.
A vaccine eliciting strong IgA responses could revolutionize HIV prevention by protecting the virus’s primary entry points.
The future of prostate cancer vaccines lies in combination therapies that harness the strengths of multiple modalities.
11th of November, 2024
Learn more12th of November, 2024
Learn more13th of November, 2024
Learn more14th of November, 2024
Learn moreThis website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings
